Variant/Haplotypes	Drug(s)	Phenotype Category	Significance	Sentence	Allele Of Frequency In Cases	Allele Of Frequency In Controls	Ratio Stat Type	Effect
rs1051740	carbamazepine	Efficacy	no	Genotype TT is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes CC + CT.	C	T	OR	0.98
rs2234922	carbamazepine	Efficacy	no	Genotype AA is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes AG + GG.	A	G	OR	0.952
rs1800497	bupropion	Efficacy	no	Genotypes AA + AG are not associated with response to bupropion in people with Tobacco Use Disorder as compared to genotype GG.	A	G	OR	0.82
rs2160734	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele T.	C	T	HR	1.754
rs9923231	warfarin	Efficacy	yes	Genotype CT is associated with decreased response to warfarin in people with Ventricular Dysfunction, Left as compared to genotype TT.	T	C	OR	4.89
rs2279343	bupropion	Efficacy	yes	Genotype AA is associated with increased response to bupropion in people with Tobacco Use Disorder as compared to genotypes AG + GG.	A	G	OR	0.521
rs4810083	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	0.89
rs266729	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CG + GG.	G	C	OR	1.219
rs3821799	pioglitazone	Efficacy	no	Genotypes CT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype CC.	C	T	OR	1.131
rs3774261	pioglitazone	Efficacy	no	Genotypes AG + GG are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype AA.	G	A	OR	1.209
rs2082940	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.	C	T	OR	1.303
rs1063538	pioglitazone	Efficacy	no	Genotypes CC + CT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	C	T	OR	1.255
rs2231142	sunitinib	Efficacy	no	Genotype TT is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes GG + GT.	T	G	OR	0.8
rs2231142	allopurinol	Efficacy	yes	Genotypes GT + TT are associated with decreased response to allopurinol in people with Gout as compared to genotype GG.	G	T	OR	0.36
rs10011796	allopurinol	Efficacy	no	Genotypes CT + TT are not associated with response to allopurinol in people with Gout as compared to genotype CC.	C	T	OR	0.85
rs249429	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	1.471
rs1045642	carbamazepine	Efficacy	no	Genotype GG is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes AA + AG.	G	A	OR	1.06
rs1045642	imatinib	Efficacy	no	Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	G	A	OR	0.62
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	OR	0.5
rs1800497	bupropion	Efficacy	no	Genotypes AA + AG are not associated with response to bupropion in people with Tobacco Use Disorder as compared to genotype GG.	A	G	OR	0.82
rs2160734	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele T.	C	T	HR	1.754
rs9923231	warfarin	Efficacy	yes	Genotype CT is associated with decreased response to warfarin in people with Ventricular Dysfunction, Left as compared to genotype TT.	T	C	OR	4.89
rs2279343	bupropion	Efficacy	yes	Genotype AA is associated with increased response to bupropion in people with Tobacco Use Disorder as compared to genotypes AG + GG.	A	G	OR	0.521
rs4810083	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	0.89
rs266729	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CG + GG.	G	C	OR	1.219
rs3821799	pioglitazone	Efficacy	no	Genotypes CT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype CC.	C	T	OR	1.131
rs3774261	pioglitazone	Efficacy	no	Genotypes AG + GG are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype AA.	G	A	OR	1.209
rs2082940	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.	C	T	OR	1.303
rs1063538	pioglitazone	Efficacy	no	Genotypes CC + CT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	C	T	OR	1.255
rs2231142	sunitinib	Efficacy	no	Genotype TT is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes GG + GT.	T	G	OR	0.8
rs2231142	allopurinol	Efficacy	yes	Genotypes GT + TT are associated with decreased response to allopurinol in people with Gout as compared to genotype GG.	G	T	OR	0.36
rs10011796	allopurinol	Efficacy	no	Genotypes CT + TT are not associated with response to allopurinol in people with Gout as compared to genotype CC.	C	T	OR	0.85
rs249429	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	1.471
rs1045642	carbamazepine	Efficacy	no	Genotype GG is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes AA + AG.	G	A	OR	1.06
rs1045642	imatinib	Efficacy	no	Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	G	A	OR	0.62
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	OR	0.5
rs9923231	warfarin	Efficacy	yes	Genotype CT is associated with decreased response to warfarin in people with Ventricular Dysfunction, Left as compared to genotype TT.	T	C	OR	4.89
rs2279343	bupropion	Efficacy	yes	Genotype AA is associated with increased response to bupropion in people with Tobacco Use Disorder as compared to genotypes AG + GG.	A	G	OR	0.521
rs4810083	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	0.89
rs266729	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CG + GG.	G	C	OR	1.219
rs3821799	pioglitazone	Efficacy	no	Genotypes CT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype CC.	C	T	OR	1.131
rs3774261	pioglitazone	Efficacy	no	Genotypes AG + GG are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype AA.	G	A	OR	1.209
rs2082940	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.	C	T	OR	1.303
rs1063538	pioglitazone	Efficacy	no	Genotypes CC + CT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	C	T	OR	1.255
rs2231142	sunitinib	Efficacy	no	Genotype TT is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes GG + GT.	T	G	OR	0.8
rs2231142	allopurinol	Efficacy	yes	Genotypes GT + TT are associated with decreased response to allopurinol in people with Gout as compared to genotype GG.	G	T	OR	0.36
rs10011796	allopurinol	Efficacy	no	Genotypes CT + TT are not associated with response to allopurinol in people with Gout as compared to genotype CC.	C	T	OR	0.85
rs249429	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	1.471
rs1045642	carbamazepine	Efficacy	no	Genotype GG is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes AA + AG.	G	A	OR	1.06
rs1045642	imatinib	Efficacy	no	Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	G	A	OR	0.62
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	OR	0.5
rs4810083	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	0.89
rs266729	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CG + GG.	G	C	OR	1.219
rs3821799	pioglitazone	Efficacy	no	Genotypes CT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype CC.	C	T	OR	1.131
rs3774261	pioglitazone	Efficacy	no	Genotypes AG + GG are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype AA.	G	A	OR	1.209
rs2082940	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.	C	T	OR	1.303
rs1063538	pioglitazone	Efficacy	no	Genotypes CC + CT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	C	T	OR	1.255
rs2231142	sunitinib	Efficacy	no	Genotype TT is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes GG + GT.	T	G	OR	0.8
rs2231142	allopurinol	Efficacy	yes	Genotypes GT + TT are associated with decreased response to allopurinol in people with Gout as compared to genotype GG.	G	T	OR	0.36
rs10011796	allopurinol	Efficacy	no	Genotypes CT + TT are not associated with response to allopurinol in people with Gout as compared to genotype CC.	C	T	OR	0.85
rs249429	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	1.471
rs1045642	carbamazepine	Efficacy	no	Genotype GG is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes AA + AG.	G	A	OR	1.06
rs1045642	imatinib	Efficacy	no	Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	G	A	OR	0.62
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	OR	0.5
rs266729	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CG + GG.	G	C	OR	1.219
rs3821799	pioglitazone	Efficacy	no	Genotypes CT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype CC.	C	T	OR	1.131
rs3774261	pioglitazone	Efficacy	no	Genotypes AG + GG are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype AA.	G	A	OR	1.209
rs2082940	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.	C	T	OR	1.303
rs1063538	pioglitazone	Efficacy	no	Genotypes CC + CT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	C	T	OR	1.255
rs2231142	sunitinib	Efficacy	no	Genotype TT is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes GG + GT.	T	G	OR	0.8
rs2231142	allopurinol	Efficacy	yes	Genotypes GT + TT are associated with decreased response to allopurinol in people with Gout as compared to genotype GG.	G	T	OR	0.36
rs10011796	allopurinol	Efficacy	no	Genotypes CT + TT are not associated with response to allopurinol in people with Gout as compared to genotype CC.	C	T	OR	0.85
rs249429	metformin	Efficacy	no	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	C	T	OR	1.471
rs1045642	carbamazepine	Efficacy	no	Genotype GG is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes AA + AG.	G	A	OR	1.06
rs1045642	imatinib	Efficacy	no	Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	G	A	OR	0.62
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	OR	0.5
rs1045642	carbamazepine	Efficacy	no	Genotype GG is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes AA + AG.	G	A	OR	1.06
rs1045642	imatinib	Efficacy	no	Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	G	A	OR	0.62
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	OR	1.754
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	HR	1.7
rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	OR	0.5
